Back

Effects of dapagliflozin on hospitalizations for heart failure according to severity of inpatient treatment course: the DELIVER Trial

21 May 2023 (09:00 - 09:45)
Organised by: Logo
Congress Presentation Part of: Heart failure with preserved ejection fraction (HFpEF) 1 Heart Failure with Preserved Ejection Fraction (HFpEF) HFA Premium Access Heart Failure 2023 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Safia Chatur

Massachusetts General Hospital - Harvard Medical School, Boston (United States of America)

7 More presentations in this session

Presentation thumbnail
Safety and clinical effects of sodium-glucose cotransporter-2 inhibitors in transthyretin amyloid cardiomyopathy
Doctor A. Nalbandian (New York, US)
Abstract Slides
Presentation thumbnail
Impact of temporary LV systolic dysfunction on long-term clinical outcome in patients with preserved ejection fraction after acute myocardial infarction
Doctor J. Kim (Seoul, KR)
Abstract Slides
Presentation thumbnail
Vascular stiffness, cardiac chamber stiffness and cardiovascular risk factors in women versus men with pre-HFpEF; a report from the PARABLE trial.
Doctor B. Wong (Dublin, IE)
Abstract Slides
Presentation thumbnail
Left-to-right ventricular volume ratio and outcome in heart failure with preserved ejection fraction
Doctor A. Aimo (Pisa, IT)
Abstract Slides
Presentation thumbnail
Coronary microvascular dysfunction, central and overall obesity and metabolic and fibrotic biomarkers in patients with heart failure with preserved ejection fraction (data from PROMIS-HFpEF)
Mr M. Erhardsson (Stockholm, SE)
Abstract Slides

Access the full session

Session thumbnail
Heart failure with preserved ejection fraction (HFpEF) 1

The Event

Event poster

Heart Failure 2023

21 May 2023 09:00 CET
You may be interested in
thumbnail
Congress Presentation
Renal and hemodynamic effects of dapagliflozin in recently hospitalized patients with heart failure with mildly reduced or preserved ejection fraction in DELIVER
22 May 2023
thumbnail
Congress Presentation
GLP-1-ra and heart failure-related outcomes in patients with and without a history of heart failure: a systematic review and meta-analysis.
23 May 2023
thumbnail
Congress Presentation
Adverse clinical course and outcomes in patients with type 2 diabetes hospitalised for acute heart failure with preserved ejection fraction
20 May 2023
thumbnail
Congress Presentation
Hospitalization as a strategic time for optimization of disease modifying therapies in patients with HFrEF and HFmrEF
21 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources